Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

Shares of Regeneron Pharmaceuticals, Inc. REGN have gained 13.5% in the year so far against the industry’s decline of 2.8%.

Patient advocacy group uses report data to push solutions on air pollution, access to medicine, health equity 2024 Asthma ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

Potential new benefit for home health care for seniors to be funded through Medicare drug price negotiations, likely ...

The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals. It has its own manufacturing facility at Goa. It sells products through independent ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

NICE has backed the drug after rejecting it earlier this year due to an “improved commercial arrangement” with Sanofi – in other words a price discount. Cablivi was also recommended for NHS ...

The objectives of this symposium were to improve attendees’ knowledge on ADT, including the different therapeutic options ...

WeightWatchers said it will sell compounded versions of semaglutide — the key ingredient in Novo Nordisk's Ozempic and Wegovy ...

The advent of LLMs has reopened a debate about the limits of machine intelligence — and requires new benchmarks of what reasoning consists of.

As of September 27 at 1:04 PM EDT. Market Open.